Financials

  • Market Capitalization 23.82 M
  • Employee 11
  • Founded 1996
  • CEO N/A
  • Website www.cellectar.com
  • Headquarter Delaware, United States
  • FIGI BBG000G9WFQ5
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.35
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4508
GNTA
Genenta Science S.p.A. - American Depositary Shares
1.03 USD+4.04%-18.25%-34.81%-72.68%24.14 M USD
4511
TVRD
Tvardi Therapeutics, Inc. - Common Stock
1.81 USD0.00%-2.69%-26.42%-49.72%24.14 M USD
4516
MRKR
Marker Therapeutics, Inc. - Common Stock
1.38 USD-5.48%-0.72%+15.97%+40.82%23.01 M USD
4530
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.59 USD-19.59%+1.34%+8.03%+132.31%22.00 M USD

Noticias